PhRMA is fighting the FDA's plans to post preliminary information about the potentially harmful side effects of drugs, saying that the early warning system is likely to lead to "irrational fears" and confusion among consumers. The FDA has proposed launching a "Drug Watch" page on its website, listing the safety concerns it had under investigation. PhRMA President Billy Tauzin says that bad data on the site could prompt patients to stop taking medications that they need.
- read this story from Pharmaceutical News for more